Patient Guide: Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 81 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04306315
Status: ACTIVE_NOT_RECRUITING
Condition: Psoriasis Vulgaris
Phase: PHASE4

Where You Can Participate

This study is available at 81 locations across the country.

Top locations include:
  • • Brussels,
  • • Ham-sur-Heure-Nalinnes,
  • • Leuven,
  • • And 78 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight - Join Clinical Trial NCTNCT04306315

How to Join This Clinical Trial - NCTNCT04306315

Learn how to participate in this PHASE4 trial studying an investigational therapy for Psoriasis Vulgaris. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Psoriasis Vulgaris. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Psoriasis Vulgaris
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04306315 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 81 locations. Find a study site near you:

Clinical Research Site

Brussels, 1200 - Belgium

Status: Contact for availability

Clinical Research Site

Ham-sur-Heure-Nalinnes, 6120 - Belgium

Status: Contact for availability

Clinical Research Site

Leuven, 3000 - Belgium

Status: Contact for availability

Clinical Research Site

Liège, B-4000 - Belgium

Status: Contact for availability

Clinical Research Site

Kutná Hora, 284 01 - Czechia

Status: Contact for availability

Clinical Research Site

Nový Jičín, 741 01 - Czechia

Status: Contact for availability

Clinical Research Site

Plzen-Bory, 305 99 - Czechia

Status: Contact for availability

Clinical Research Site

Amiens, Somme 80054 - France

Status: Contact for availability

Clinical Research Site

Saint-Priest-en-Jarez, 42270 - France

Status: Contact for availability

Clinical Research Site

Toulouse, 31059 - France

Status: Contact for availability

And 71 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Psoriasis Vulgaris:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships